Core Laboratories (NYSE:CLB) Price Target Cut to $12.00 by Analysts at Stifel Nicolaus

Core Laboratories (NYSE:CLB - Free Report) had its price target reduced by Stifel Nicolaus from $13.00 to $12.00 in a research report released on Wednesday,Benzinga reports. Stifel Nicolaus currently has a hold rating on the oil and gas company's stock.

CLB has been the subject of a number of other research reports. Wall Street Zen cut shares of Core Laboratories from a "hold" rating to a "sell" rating in a report on Friday, April 25th. Citigroup lowered their price objective on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating for the company in a research note on Tuesday, May 13th.

Core Laboratories Stock Down 2.1%

CLB traded down $0.24 during trading on Wednesday, reaching $11.41. 298,756 shares of the stock were exchanged, compared to its average volume of 406,986. The stock has a market cap of $534.90 million, a P/E ratio of 19.34, a price-to-earnings-growth ratio of 3.51 and a beta of 1.41. Core Laboratories has a twelve month low of $10.14 and a twelve month high of $25.13. The stock's 50 day moving average price is $11.83 and its two-hundred day moving average price is $14.08. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.64 and a current ratio of 2.21.

Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). Core Laboratories had a net margin of 5.41% and a return on equity of 15.06%. The company had revenue of $123.59 million during the quarter, compared to analyst estimates of $125.09 million. During the same quarter in the prior year, the firm earned $0.19 earnings per share. Core Laboratories's revenue for the quarter was down 4.7% on a year-over-year basis. Equities analysts expect that Core Laboratories will post 0.96 EPS for the current year.

Core Laboratories Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Monday, May 5th were issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend was Monday, May 5th. Core Laboratories's payout ratio is 6.78%.

Hedge Funds Weigh In On Core Laboratories

Several large investors have recently bought and sold shares of CLB. Raymond James Financial Inc. purchased a new stake in shares of Core Laboratories during the 4th quarter valued at $6,760,000. Amundi increased its holdings in Core Laboratories by 194.8% in the 4th quarter. Amundi now owns 32,968 shares of the oil and gas company's stock worth $600,000 after acquiring an additional 21,783 shares during the last quarter. Intech Investment Management LLC purchased a new stake in Core Laboratories in the 4th quarter worth about $716,000. American Century Companies Inc. increased its holdings in Core Laboratories by 12.2% in the 4th quarter. American Century Companies Inc. now owns 96,372 shares of the oil and gas company's stock worth $1,668,000 after acquiring an additional 10,472 shares during the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new stake in Core Laboratories in the 4th quarter worth about $149,000. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.